Sherbrooke Park Advisers’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,241
Closed -$133K 527
2025
Q2
$133K Buy
+12,241
New +$160K 0.06% 433
2024
Q1
Sell
-20,799
Closed -$142K 836
2023
Q4
$142K Buy
20,799
+4,286
+26% +$23.8K 0.07% 367
2023
Q3
$82.6K Buy
+16,513
New +$114K 0.03% 469

Other funds holding AXGN

Sherbrooke Park Advisers's AXGN Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Axogen (AXGN) in Q3 2025, closing a stake of 12,241 shares — an estimated $133K sold.

Sherbrooke Park Advisers first reported a position in AXGN in Q3 2023 and held it in 3 quarters. The position peaked at $142K in Q4 2023. 171 funds tracked by Wall St. Rank hold AXGN as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining Axogen position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 12,241 Axogen shares in Q3 2025, an estimated $133K.
  • Sherbrooke Park Advisers first reported a position in Axogen in Q3 2023 and held it in 3 quarters.
  • Sherbrooke Park Advisers's Axogen position peaked at $142K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Axogen as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.